Who
Scott Kellen
CFO & Secretary
Company insider
Files Form 4 as: CFO & Secretary, DiaMedica Therapeutics; Chief Financial Officer, Sun BioPharma; COO, CFO, VP of Finance & Secy, Kips Bay Medical.
In numbers
- Trades disclosed
- 33
- Buys
- 10
- Sells
- 0
- Bought
- $119K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 7 Mar 2011
- Last trade
- 1 Jun 2026
- Last filed
- 3 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 3 Jun 2026 | DMAC DiaMedica Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —162,000 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | DMAC DiaMedica Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —162,000 at $0.00 | filing |
| 1 Jun 2025filed 3 Jun 2025 | DMAC DiaMedica Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —225,000 at $0.00 | filing |
| 1 Jun 2024filed 3 Jun 2024 | DMAC DiaMedica Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 23 Jun 2023filed 26 Jun 2023 | DMAC DiaMedica TherapeuticsBiotechnology | SEC FORM 4 Bought | $39K10,000 at $3.91 | filing |
| 1 Jun 2023filed 2 Jun 2023 | DMAC DiaMedica Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —67,000 at $0.00 | filing |
| 1 Jun 2022filed 2 Jun 2022 | DMAC DiaMedica Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 16 Aug 2021filed 16 Aug 2021 | DMAC DiaMedica TherapeuticsBiotechnology | SEC FORM 4 Bought | $32K10,000 at $3.15 | filing |
| 28 Jul 2021filed 29 Jul 2021 | DMAC DiaMedica Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 9 Nov 2020filed 10 Nov 2020 | DMAC DiaMedica TherapeuticsBiotechnology | SEC FORM 4 Bought | $8,3802,000 at $4.19 | filing |
| 1 Jun 2020filed 2 Jun 2020 | DMAC DiaMedica Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 19 Aug 2019filed 19 Aug 2019 | DMAC DiaMedica TherapeuticsBiotechnology | SEC FORM 4 Bought | $7,2903,000 at $2.43 | filing |
| 24 Jun 2019filed 26 Jun 2019 | DMAC DiaMedica Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —99,750 at $0.00 | filing |
| 24 May 2019filed 28 May 2019 | DMAC DiaMedica TherapeuticsBiotechnology | SEC FORM 4 Bought | $12K4,000 at $2.94 | filing |
| 11 Dec 2018filed 11 Dec 2018 | DMAC DiaMedica TherapeuticsBiotechnology | SEC FORM 4 Bought | $5,0001,250 at $4.00 | filing |
| 27 Feb 2018filed 1 Mar 2018 | Sun BioPharmaoption or derivative | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 20 Feb 2018filed 22 Feb 2018 | Sun BioPharma | SEC FORM 4 Bought | —1,000 | filing |
| 20 Feb 2018filed 22 Feb 2018 | Sun BioPharmaoption or derivative | SEC FORM 4 Code P | —1,000 | filing |
| 17 Mar 2017filed 21 Mar 2017 | Sun BioPharmaoption or derivative | SEC FORM 4 Code A | —93,000 at $0.00 | filing |
| 12 Dec 2016filed 14 Dec 2016 | Sun BioPharmaoption or derivative | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.